Catalyst Pharmaceuticals
CPRX
$14.89
Share price
1.43%
Change (1 day)
-5.52%
Change (1 year)
Categories
Catalyst Pharmaceuticals (CPRX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $82.23 M
According to Catalyst Pharmaceuticals's latest financial reports the company's total liabilities are $82.23 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Catalyst Pharmaceuticals - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $82.23 M | 9.34% |
| 2022-12-31 | $75.2 M | 142.95% |
| 2021-12-31 | $30.95 M | 36.04% |
| 2020-12-31 | $22.75 M | -8.04% |
| 2019-12-31 | $24.74 M | 156.01% |
| 2018-12-31 | $9.66 M | 118.51% |
| 2017-12-31 | $4.42 M | 84.48% |
| 2016-12-31 | $2.39 M | -48.16% |
| 2015-12-31 | $4.62 M | -46.63% |
| 2014-12-31 | $8.66 M | 117.83% |
| 2013-12-31 | $3.97 M | 83.57% |
| 2012-12-31 | $2.16 M | -12.92% |
| 2011-12-31 | $2.48 M | 693.27% |
| 2010-12-31 | $0.31 M | -9.99% |
| 2009-12-31 | $0.34 M | -76.34% |
| 2008-12-31 | $1.47 M | 312.35% |
| 2007-12-31 | $0.35 M | -53.79% |
| 2006-12-31 | $0.77 M | 125.33% |
| 2005-12-31 | $0.34 M | 405.88% |
| 2004-12-31 | $0.06 M | |
| 2002-12-31 | $0.06 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 120,026.96% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 166,758.80% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 41,716.55% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $2.40 B | 2,824.91% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.30 B | 273.80% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 2,198.41% | 🇺🇸 USA |